Is Accelerate Diagnostics, Inc. technically bullish or bearish?
2025-09-20 19:05:56As of 7 July 2025, the technical trend for Accelerate Diagnostics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the moving averages indicate a bearish trend on the daily. The Bollinger Bands are sideways weekly but mildly bearish monthly, and both KST and Dow Theory show bearish and no trend signals, respectively. In terms of performance, the stock has returned -100% over the past month, year-to-date, year, three years, five years, and ten years, significantly underperforming the S&P 500, which has returns of 2.33%, 12.22%, 17.14%, 70.41%, 96.61%, and 231.64% in the same periods....
Read MoreIs Accelerate Diagnostics, Inc. overvalued or undervalued?
2025-09-20 17:39:31As of 3 August 2017, the valuation grade for Accelerate Diagnostics, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -0.01 and an EV to Sales ratio of 4.11, which suggests that investors are paying a high price relative to the company's sales. Additionally, the EV to EBITDA ratio stands at -1.51, further highlighting the company's financial struggles. In comparison to its peers, Accelerate Diagnostics, Inc. has a P/E ratio of 0.0000, while Clearpoint Neuro, Inc. has a P/E of -13.9815 and Stereotaxis, Inc. has a P/E of -11.2314, all indicating a challenging environment for companies in this sector. The stock has underperformed significantly, with a year-to-date return of -100.0% compared to the S&P 500's return of 12.22%, reinforcing the notion that th...
Read More





